ESCALON MEDICAL CORP (ESMC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue TTM

0 10M 20M 30M Q4 '11: 26.9M Q1 '12: 21.9M Q2 '12: 18.5M Q3 '12: 15.2M Q4 '12: 11.5M Q1 '13: 11.3M Q2 '13: 11.8M Q3 '13: 11.4M Q4 '13: 11.5M Q1 '14: 12.4M Q2 '14: 11.8M Q3 '14: 12.2M Q4 '14: 12.4M Q1 '15: 11.9M Q2 '15: 12.5M Q3 '15: 12.8M Q4 '15: 13.1M Q1 '16: 13.3M Q2 '16: 12.6M Q3 '16: 12.2M Q4 '16: 11.6M Q1 '17: 11.1M Q2 '17: 11.3M Q3 '17: 11M Q4 '17: 11.2M Q1 '18: 11.5M Q2 '18: 11.8M Q3 '18: 11.5M Q4 '18: 11.4M Q1 '19: 11M Q2 '19: 10.1M Q3 '19: 10.1M Q4 '19: 9.6M Q1 '20: 9.7M Q2 '20: 10M Q3 '20: 9.7M Q4 '20: 9.4M Q1 '21: 9.5M Q2 '21: 9.7M Q3 '21: 9.7M Q4 '21: 10.5M Q1 '22: 10.7M Q2 '22: 10.5M Q3 '22: 10.6M Q4 '22: 10.7M Q1 '23: 10.6M Q2 '23: 10.9M Q3 '23: 12M Q4 '23: 12.2M Q1 '24: 12.5M Q2 '24: 12.4M Q3 '24: 11.6M Q4 '24: 12M Q1 '25: 11.8M Q2 '25: 12.2M Q3 '25: 12.9M Q4 '25: 12M Q1 '26: 11.9M Q2 '26: 12.3M Q3 '26: 11.4M Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

Gross Profit TTM

0 2M 4M 6M Q4 '19: 4.6M Q1 '20: 4.7M Q2 '20: 4.8M Q3 '20: 4.6M Q4 '20: 4.2M Q1 '21: 4M Q2 '21: 3.9M Q3 '21: 3.8M Q4 '21: 4.4M Q1 '22: 4.5M Q2 '22: 4.5M Q3 '22: 4.5M Q4 '22: 4.6M Q1 '23: 4.7M Q2 '23: 4.7M Q3 '23: 5.5M Q4 '23: 5.5M Q1 '24: 5.7M Q2 '24: 5.7M Q3 '24: 5.1M Q4 '24: 5.1M Q1 '25: 5.1M Q2 '25: 5.4M Q3 '25: 5.9M Q4 '25: 5.5M Q1 '26: 5.4M Q2 '26: 5.4M Q3 '26: 4.7M Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-6M -4M -2M 0 2M 4M 6M Q4 '11: -4.7M Q1 '12: -4.3M Q2 '12: -3.5M Q3 '12: -2.1M Q4 '12: -1.3M Q1 '13: -1.5M Q2 '13: -1.4M Q3 '13: -1.4M Q4 '13: -1.2M Q1 '14: -597.5K Q2 '14: -796.4K Q3 '14: -389.2K Q4 '14: -357.5K Q1 '15: -835.5K Q2 '15: -822.9K Q3 '15: -927.8K Q4 '15: -1.1M Q1 '16: -905.2K Q2 '16: -1.1M Q3 '16: -1.2M Q4 '16: -1.1M Q1 '17: -1.2M Q2 '17: -1M Q3 '17: -1M Q4 '17: -626.9K Q1 '18: -268.9K Q2 '18: 18.8K Q3 '18: 302 Q4 '18: 204.7K Q1 '19: 188.6K Q2 '19: -283.1K Q3 '19: -168.6K Q4 '19: -253K Q1 '20: -343.3K Q2 '20: -789.7K Q3 '20: -940.2K Q4 '20: -1.4M Q1 '21: -1.5M Q2 '21: -680.8K Q3 '21: -684.7K Q4 '21: -33.7K Q1 '22: -26.6K Q2 '22: -179.4K Q3 '22: -339.1K Q4 '22: -470.1K Q1 '23: -601.5K Q2 '23: -552.4K Q3 '23: 329K Q4 '23: 478.5K Q1 '24: 778.8K Q2 '24: 708.3K Q3 '24: -37.9K Q4 '24: -104.5K Q1 '25: -115.8K Q2 '25: 210.6K Q3 '25: 643.3K Q4 '25: 133.2K Q1 '26: -42.6K Q2 '26: -199.7K Q3 '26: -895K Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

Net Income TTM

-9M -6M -3M 0 3M 6M 9M Q4 '11: -5.8M Q1 '12: -5.9M Q2 '12: -8.4M Q3 '12: -7.1M Q4 '12: -5.9M Q1 '13: -5.6M Q2 '13: 1.9M Q3 '13: 2.3M Q4 '13: 2.8M Q1 '14: 3.3M Q2 '14: -832.8K Q3 '14: -460.8K Q4 '14: -381.9K Q1 '15: -854.1K Q2 '15: -819.6K Q3 '15: -849.2K Q4 '15: -541.2K Q1 '16: -375.5K Q2 '16: -566.5K Q3 '16: -704.3K Q4 '16: -1.2M Q1 '17: -1.3M Q2 '17: -1.1M Q3 '17: -1.1M Q4 '17: -726.9K Q1 '18: -391.9K Q2 '18: 384.3K Q3 '18: 372.1K Q4 '18: 583.7K Q1 '19: 596.5K Q2 '19: -332.7K Q3 '19: -191.5K Q4 '19: -493.5K Q1 '20: 175.6K Q2 '20: -281.8K Q3 '20: -431.9K Q4 '20: -650.3K Q1 '21: -1.5M Q2 '21: -694.4K Q3 '21: -704K Q4 '21: -52K Q1 '22: 461.8K Q2 '22: 310.1K Q3 '22: 126.9K Q4 '22: 18.1K Q1 '23: -619.9K Q2 '23: -572.8K Q3 '23: 333.2K Q4 '23: 456.8K Q1 '24: 756.4K Q2 '24: 686.1K Q3 '24: -61.3K Q4 '24: -125.3K Q1 '25: -136.3K Q2 '25: 186.1K Q3 '25: 619.7K Q4 '25: 105.5K Q1 '26: -102.1K Q2 '26: -250.5K Q3 '26: 1.9M Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

Cost of Revenue TTM

0 2.5M 5M 7.5M Q4 '19: 5M Q1 '20: 5M Q2 '20: 5.1M Q3 '20: 5M Q4 '20: 5.2M Q1 '21: 5.5M Q2 '21: 5.7M Q3 '21: 5.8M Q4 '21: 6M Q1 '22: 6.2M Q2 '22: 6.1M Q3 '22: 6.2M Q4 '22: 6.1M Q1 '23: 6M Q2 '23: 6.2M Q3 '23: 6.4M Q4 '23: 6.7M Q1 '24: 6.8M Q2 '24: 6.7M Q3 '24: 6.5M Q4 '24: 6.8M Q1 '25: 6.8M Q2 '25: 6.8M Q3 '25: 7.1M Q4 '25: 6.5M Q1 '26: 6.5M Q2 '26: 6.9M Q3 '26: 6.7M Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Operating Cash Flow TTM

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q4 '11: -904.7K Q1 '12: -31.4K Q2 '12: -663.2K Q3 '12: -1.2M Q4 '12: -700.6K Q1 '13: -1M Q2 '13: -993.5K Q3 '13: -793.8K Q4 '13: -1.9M Q1 '14: -1.5M Q2 '14: -988.5K Q3 '14: -848.5K Q4 '14: -622.6K Q1 '15: -1.3M Q2 '15: -1.2M Q3 '15: -1.2M Q4 '15: -456.5K Q1 '16: -42.8K Q2 '16: -382.1K Q3 '16: -674.3K Q4 '16: -1.2M Q1 '17: -1.2M Q2 '17: -1.1M Q3 '17: -848.1K Q4 '17: -506K Q1 '18: -514.9K Q2 '18: -270.4K Q3 '18: 210.1K Q4 '18: 106.7K Q1 '19: 293.1K Q2 '19: 139.2K Q3 '19: -348.6K Q4 '19: -472.7K Q1 '20: -477.4K Q2 '20: -359.7K Q3 '20: 228K Q4 '20: -168.5K Q1 '21: 365.4K Q2 '21: 683.8K Q3 '21: 341.9K Q4 '21: 838.7K Q1 '22: -95.8K Q2 '22: -459.4K Q3 '22: -598.2K Q4 '22: -1M Q1 '23: -966.9K Q2 '23: -739.1K Q3 '23: -482.6K Q4 '23: 325.1K Q1 '24: 519.6K Q2 '24: 157.7K Q3 '24: 92K Q4 '24: -602.8K Q1 '25: -453.5K Q2 '25: 169.6K Q3 '25: 25.1K Q4 '25: 380.7K Q1 '26: 432.4K Q2 '26: -386K Q3 '26: -135.7K Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

Free Cash Flow TTM

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q4 '11: -1.2M Q1 '12: -224.3K Q2 '12: -843.5K Q3 '12: -1.4M Q4 '12: -701.7K Q1 '13: -1M Q2 '13: -996.9K Q3 '13: -802.4K Q4 '13: -1.9M Q1 '14: -1.5M Q2 '14: -994.2K Q3 '14: -854.3K Q4 '14: -625.3K Q1 '15: -1.3M Q2 '15: -1.2M Q3 '15: -1.2M Q4 '15: -492.8K Q1 '16: -132.2K Q2 '16: -458.3K Q3 '16: -746.2K Q4 '17: -506K Q1 '18: -517.1K Q2 '18: -272.6K Q3 '18: 207.9K Q4 '18: 77.4K Q1 '19: 259.4K Q2 '19: 105.6K Q3 '19: -382.2K Q4 '19: -494.8K Q1 '20: -502.4K Q2 '20: -411.3K Q3 '20: 173.4K Q4 '20: -228.2K Q3 '23: -489.3K Q4 '23: 318.5K Q1 '24: 494.6K Q2 '24: 110.7K Q3 '24: 61K Q4 '24: -643.1K Q1 '25: -475.4K Q2 '25: 169.6K Q3 '25: 15.8K Q4 '25: 376.8K Q1 '26: 424.1K Q2 '26: -394.3K Q3 '26: -144K Q3 '12 Q1 '14 Q3 '15 Q1 '18 Q3 '19 Q3 '23 Q1 '25 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 5M 10M 15M Q1 '11: 7.5M Q2 '11: 7.5M Q3 '11: 7.5M Q1 '12: 7.5M Q2 '12: 7.5M Q3 '12: 7.5M Q1 '13: 7.5M Q2 '13: 7.5M Q3 '13: 7.5M Q1 '14: 7.6M Q2 '14: 7.5M Q3 '14: 7.5M Q1 '15: 7.5M Q2 '15: 7.5M Q3 '15: 7.5M Q1 '16: 7.5M Q2 '16: 7.5M Q3 '16: 7.5M Q1 '17: 7.6M Q2 '17: 7.6M Q3 '17: 7.6M Q1 '18: 7.6M Q2 '18: 7.6M Q3 '18: 7.6M Q1 '19: 7.4M Q2 '19: 7.4M Q3 '19: 12M Q1 '20: 12.2M Q2 '20: 7.4M Q3 '20: 7.4M Q1 '21: 7.4M Q2 '21: 12.7M Q3 '21: 7.4M Q1 '22: 12.9M Q2 '22: 7.4M Q3 '22: 7.4M Q1 '23: 7.4M Q2 '23: 7.4M Q3 '23: 13.5M Q1 '24: 7.4M Q2 '24: 7.4M Q3 '24: 7.4M Q1 '25: 7.4M Q2 '25: 14.1M Q3 '25: 14.2M Q1 '26: 7.4M Q2 '26: 14.4M Q3 '26: 14.5M Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.20 -0.80 -0.40 0.00 0.40 0.80 1.20 Q4 '11: -0.78 Q1 '12: -0.79 Q2 '12: -1.12 Q3 '12: -0.95 Q4 '12: -0.79 Q1 '13: -0.75 Q2 '13: 0.25 Q3 '13: 0.30 Q4 '13: 0.35 Q1 '14: 0.41 Q2 '14: -0.13 Q3 '14: -0.08 Q4 '14: -0.05 Q1 '15: -0.11 Q2 '15: -0.11 Q3 '15: -0.11 Q4 '15: -0.07 Q1 '16: -0.05 Q2 '16: -0.08 Q3 '16: -0.10 Q4 '16: -0.16 Q1 '17: -0.17 Q2 '17: -0.14 Q3 '17: -0.14 Q4 '17: -0.09 Q1 '18: -0.05 Q2 '18: 0.05 Q3 '18: 0.04 Q4 '18: 0.06 Q1 '19: 0.06 Q2 '19: -0.06 Q3 '19: -0.04 Q4 '19: -0.04 Q1 '20: 0.02 Q2 '20: -0.04 Q3 '20: -0.06 Q4 '20: -0.12 Q1 '21: -0.20 Q2 '21: -0.10 Q3 '21: -0.10 Q4 '21: -0.01 Q1 '22: 0.04 Q2 '22: 0.02 Q3 '22: -0.00 Q4 '22: -0.00 Q1 '23: -0.07 Q2 '23: -0.06 Q3 '23: 0.02 Q4 '23: 0.03 Q1 '24: 0.08 Q2 '24: 0.07 Q3 '24: 0.01 Q4 '24: -0.02 Q1 '25: -0.03 Q2 '25: -0.00 Q3 '25: 0.04 Q4 '25: 0.00 Q1 '26: -0.02 Q2 '26: -0.03 Q3 '26: 0.11 Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.